P ULMONARY SURFACTANT, a developmentally regulated lipoprotein synthesized exclusively in lung alveolar type II cells, acts to reduce alveolar surface tension and is essential for normal breathing. Inadequate surfactant production by lungs of premature newborns can result in respiratory distress syndrome, a leading cause of neonatal morbidity and mortality. To define mechanisms involved in type II cell-specific, developmental, and hormonal regulation of surfactant synthesis, we have focused on the major surfactant protein, SP-A, which is lung specific, expressed in type II cells, and developmentally regulated in fetal lung in concert with surfactant phospholipid synthesis (1) . SP-A, a C-type lectin, plays an important role in immune defense within the alveolus by binding to a variety of bacterial, fungal, and viral pathogens and facilitating their uptake by alveolar macrophages, as well as by enhancing macrophage migration and cytokine production (see Ref. 2 for review). The importance of SP-A in host-defense within the alveolus is supported by the finding that mice homozygous for a targeted deletion of the SP-A gene manifested an increased susceptibility to infection by Group B streptococcus and Pneumocystis carinii, as well as defective clearance of S. aureus, P. aeruginosa, and K. pneumoniae (see Ref. 3 
for review).
Type II cell differentiation and SP-A expression in human fetal lung are induced by hormones and factors that increase cAMP; inductive effects of cAMP are dependent upon a critical O 2 tension. When midgestation human fetal lung explants are cultured in a 20% O 2 environment, epithelial cells of prealveolar ducts differentiate spontaneously into type II cells that produce SP-A; the rate of type II cell differentiation and SP-A gene expression are markedly induced by cAMP treatment (4) . By contrast, when cultured in 1-2% O 2 , type II cells fail to differentiate and no stimulatory effects of cAMP on SP-A expression are apparent (5) . Bt 2 cAMP stimulation of SP-A expression is evident only at O 2 concentrations Ն10%. These findings led us to postulate that increased vascularization of fetal lung during the third trimester of gestation results in enhanced O 2 availability to type II cell precursors, facilitating cAMP induction of type II cell differentiation and of surfactant protein gene expression (5) .
In studies using transgenic mice (6) and transfected type II cells (7-11), we found that as little as approximately 400 bp of 5Ј-flanking region from the rabbit, baboon, and human SP-A genes mediates lung type II cell-specific, developmental and cAMP-regulated expression. This region contains four response elements that are highly conserved in SP-A genes of various species. These include an element that likely binds a member of the nuclear receptor family (7) (8) (9) , an E-box (12) that binds upstream stimulatory factor-1 (13) and -2 (Gao, E., and C. Mendelson, unpublished observations), a GT-box, which binds Sp1 and other related transcription factors (10) , and a thyroid transcription factor-1 (TTF-1) binding element (TBE) for the homeodomain factor, TTF-1 (11) . Mutagenesis of any one of these elements markedly reduces basal and cAMP induction of SP-A promoter activity in transfected type II cells, suggesting the cooperative interaction of these transcription factors.
TTF-1, which is expressed selectively in developing thyroid, diencephalon, and lung epithelium from the earliest stages of organogenesis (14) , is crucial for morphogenesis of thyroid, anterior pituitary, and lung parenchyma (15) . In studies using deoxyribonuclease I footprinting and EMSA, we identified three elements (TBE1, 2, and 3) within a 255-bp region upstream of the baboon SP-A2 gene that specifically bound TTF-1 (11) . We observed that TBE1, which lies approximately 175-bp upstream of the SP-A gene, is the most highly conserved TBE among the SP-A genes of various species, exhibited the strongest footprint (11) and was most critical for basal and cAMP induction of SP-A promoter activity in transfected type II cells (16) . cAMP, acting through PKA, was found to enhance TTF-1 phosphorylation and transcriptional activity, as well as binding of type II cell nuclear proteins to TBE1 (16) . Although TTF-1 is expressed in lung epithelium from the earliest phases of development, SP-A expression is initiated only after approximately 75% of gestation is completed (17) . We have postulated that developmental changes in TTF-1 phosphorylation by PKA may enhance its binding to this TBE and its interaction with other critical transcription factors and coactivators, resulting in increased SP-A gene transcription.
In characterizing TBE1, we noted that it contained a reverse-oriented binding site for NF-B, a transcription factor known to be activated by inflammatory cytokines (see Ref. 18 for review), PKA (19, 20) , and reactive oxygen species (ROS) (21) . ROS are required for cytokine-mediated phosphorylation and degradation of inhibitor of B (IB), the inhibitory partner of NF-B. In women with intraamniotic infection associated with chorioamnionitis, amniotic fluid levels of IL-1␣ and IL-1␤ are increased (22) . The finding that the incidence of respiratory distress syndrome is decreased in infants born prematurely to such women supports a possible role of bacterially produced cytokines in fetal lung maturation. In studies by Bry et al. (23) , it was found that IL-1␣ administered intraamniotically to fetal rabbits increased expression of SP-A and SP-B by the fetal lung, and enhanced dynamic lung compliance; IL-1␣ treatment of fetal rabbit lung explants increased SP-A expression (24) . Interferon-␥, a proinflammatory cytokine also known to activate NF-B (see Ref. 18 for review), increased SP-A expression in midgestation human fetal lung explants (25) .
In light of the role of NF-B as a mediator of cytokine action, the reported effects of IL-1 on surfactant protein expression, and the presence of a putative NF-B response element within TBE1, we sought to determine whether NF-B is a component of the complex of type II cell nuclear proteins that bind to this TBE to activate SP-A promoter activity. We observed that NF-B proteins p65 and p50, as well as TTF-1, were present in the complex of nuclear proteins bound to TBE1 and that cAMP and IL-1 had additive stimulatory effects on TBE-binding activity. In cell transfection studies, we found that p50, p65, and TTF-1 cooperatively increased SP-A promoter activity; this was further enhanced by IL-1 treatment. By coimmunoprecipitation, TTF-1 was found to interact with p65 in type II cell nuclear extracts. As mentioned earlier, in studies using cultured fetal rabbit lung explants, it was found that the cytokine IL-1␣ stimulated SP-A expression (24) . To analyze the effects of IL-1 on SP-A expression in human fetal lung, as well as effects of IL-1 in combination with cAMP, human fetal lung type II cells were cultured for 3 d in control medium, in medium containing Bt 2 cAMP (1 mM), IL-1␣ or ␤ (10 ng/ml), or Bt 2 cAMP and IL-1 in combination. SP-A levels in cytoplasmic fractions isolated from these cells were analyzed by immunoblotting. A representative immunoblot is shown in Fig. 1A , and the results of densitometric scans of immunoblots from three independent experiments are shown in Fig.  1B . As we observed previously (26) , immunoreactive SP-A was present at relatively low levels in the fetal type II cells cultured in control medium and was markedly stimulated by Bt 2 cAMP treatment. Incubation of the cells in medium containing IL-1␣ or ␤ alone also caused a pronounced induction of SP-A expression as compared with control cells. When cells were incubated with Bt 2 cAMP and IL-1␣ or ␤ in combination, the levels of immunoreactive SP-A were greater than those of cells treated with either factor alone ( Fig. 1) . IL-1␣ and IL-1␤ have 62% identity in amino acid sequence and elicit highly comparable biological responses. In light of the similarity in effects of IL-1␣ and IL-1␤ on SP-A expression, subsequent experiments were carried out using IL-1␣.
TBE1 Contains a Reverse-Oriented NF-B Binding Site
In previous studies, we found that the TBE1 (heretofore referred to as TBE) specifically binds TTF-1 (11) and is critical for basal and cAMP induction of SP-A promoter activity (16) . cAMP acting through PKA enhances TTF-1 phosphorylation and transcriptional activity, as well as binding of type II cell nuclear proteins to the TBE (16) . In characterizing the TBE and surrounding nucleotides, we noted the presence of an overlapping reverse-oriented binding site for NF-B (Fig. 2) . A reverse-oriented NF-B response element was previously characterized within the 5Ј-flanking region of the murine P-selectin gene (27) . This site, which was found to mediate TNF-␣ and lipopolysaccharide enhancement of P-selectin expression, was proposed to bind p65 homodimers preferentially (27) . The TBE core sequence (CTCAAG) and flanking nucleotides shown in Fig. 2 are perfectly conserved in the bSP-A1, bSP-A2, hSP-A1, and hSP-A2 genes (11) . In previous studies, we found that mutation of the TBE to 5Ј. . . GTGCTCCCCTgtgcGGTCCT. . . 3Ј (mutated sequence is lowercase and underlined) prevented nuclear protein binding and markedly reduced transcriptional activity (11, 16) . This mutation also falls within the reverse-oriented NF-B consensus binding sequence. response element overlapping the TBE, it was of interest to analyze effects of IL-1 Ϯ Bt 2 cAMP on TBEbinding activity and to determine whether NF-B proteins p50 and p65 interact with the TBE. We first compared binding of nuclear proteins from human fetal type II cells incubated for 3 d in control medium, or in medium containing Bt 2 cAMP, IL-1␣, or IL-1␣ ϩ Bt 2 cAMP to the TBE and to an NF-B binding consensus oligonucleotide using EMSA. As can be seen, nuclear extracts from type II cells bound to the NF-B oligonucleotide as two complexes (Fig. 3A) . Treatment of cells with either Bt 2 cAMP or with IL-1␣ alone caused an increase in binding activity for the NF-B consensus probe. Binding activity was further increased in nuclear extracts of type II cells incubated with Bt 2 cAMP and IL-1␣, in combination. Pyrrolidine dithiocarbamate (PDTC), an antioxidant inhibitor of NF-B that scavenges ROS, reduced binding activity for the NF-B consensus probe of nuclear extracts from type II cells incubated in the presence of Bt 2 cAMP, IL-1␣, or Bt 2 cAMP ϩ IL-1␣. Essentially identical effects were observed when type II cells were incubated with IL-1␤ in place of IL-1␣ (data not shown).
Binding activity of the type II cell nuclear extracts from this experiment also was analyzed by EMSA using radiolabeled TBE as probe (Fig. 3B) . In contrast to the binding pattern observed using the NF-B consensus sequence, as probe, type II cell nuclear extracts bound to the TBE as a single broad band. TBE binding activity also was increased in nuclear extracts from Bt 2 cAMP-and IL-1␣-treated cells; binding was further increased in nuclear extracts of type II cells incubated with Bt 2 cAMP ϩ IL-1␣. Of great interest, was the finding that the NF-B inhibitor, PTDC, also decreased TBE-binding activity of nuclear extracts from Bt 2 cAMP-, IL-1-and IL-1 ϩ Bt 2 cAMP-treated type II cells, suggesting that NF-B may bind to the TBE. PDTC had no discernible effect on the level of TBE-binding activity in type II cells cultured in control medium (data not shown). Cells treated with PDTC were refractile and appeared viable. Furthermore, the amount of nuclear protein isolated from PDTC-treated cells was similar to that obtained from cells not treated with PDTC. In other experiments, we found that treatment of type II cells with the antioxidant inhibitor of NF-B, N-acetylcysteine (NAC), also markedly decreased binding of nuclear proteins to the TBE (data not shown).
The NF-B Inhibitor PDTC Reduces SP-A Expression in Human Fetal Lung Type II Cells and Antagonizes the Stimulatory Effect of Bt 2 cAMP
As shown in Fig. 3 , the antioxidant PDTC inhibited the binding of type II cell nuclear proteins to the NF-B consensus oligonucleotide and to the TBE and prevented the stimulatory effects of IL-1 and Bt 2 cAMP. In consideration of these findings, it was of interest to evaluate the effect of PDTC on SP-A expression in human fetal type II cells incubated with Bt 2 cAMP and IL-1. When type II cells were incubated with PDTC in the absence of Bt 2 cAMP or IL-1␣ for 72 h, the levels of immunoreactive SP-A were similar to those of control type II cells (Fig. 4) . On the other hand, PDTC blocked the stimulatory effects of Bt 2 cAMP and IL-1␣ on SP-A expression. It should be noted that treatment of human fetal type II cells with NAC also caused a marked inhibition of cAMP and IL-1 induction of SP-A expression (data not shown). These findings support our 
NF-B is a Component of the Complex of Type II Cell Nuclear Proteins that Binds to the TBE
In light of the presence of a reverse-oriented NF-B response element overlapping the TBE, and the effects of cytokines and PDTC on binding of type II cell nuclear proteins to the TBE, it was of interest to determine whether NF-B proteins are components of the complex that binds to this site. To achieve this, we used competitive EMSA and antibody-mediated supershift EMSA using TBE as radiolabeled probe and nuclear proteins from human fetal type II cells incubated for 3 d with Bt 2 cAMP. As can be seen, both nonradiolabeled NF-B consensus oligonucleotide and TBE competed with 32 P-labeled TBE for binding to type II cell nuclear proteins in a concentrationdependent manner (Fig. 5A) . A 1000-fold excess of an unrelated oligonucleotide (Nonsp. cold) failed to compete with the radiolabeled TBE for nuclear protein binding (Fig. 5B) . Although this suggests that NF-B proteins may have the capacity to bind to the TBE, it should be noted that the NF-B consensus oligonucleotide contains the sequence CTCAAC on the bottom strand in a 5Ј to 3Ј orientation. Because this is Human fetal lung type II cells were incubated in medium containing Bt 2 cAMP for 3 d. A, Type II cell nuclear proteins were incubated with 32 P-labeled TBE in the absence or presence of nonradiolabeled NF-B consensus or TBE oligonucleotides at 10-, 100-, and 1000-fold molar excess (indicated by the wedge). B, The nuclear extracts and radiolabeled TBE probe were incubated with a 1000-fold excess of the following nonradiolabeled oligonucleotides: TBE (TBE cold); NF-B consensus (NF-B cold), oligonucleotide containing the sequence 5Ј. . . TGCAGGGCCCAAGGACCTGGGCCATC. . . 3Ј (Nonsp. cold). Alternatively, the nuclear extracts and radiolabeled TBE probe were incubated with antisera (␣) to p50, p65, p50ϩp65, TTF-1, CCAAT/enhancer binding protein-␤ (C/EBP-␤) (nonspecific antibody; ␣Nonsp.), or with nonimmune IgG. To ensure that the antibodies to p50 and p65 did not interact directly with the radiolabeled TBE probe, parallel incubations were carried out using radiolabeled TBE and antisera to p50 and p65 in the absence of nuclear protein. The reaction mixtures were then analyzed by EMSA. Shown is an autoradiogram of a representative experiment; the majority of the conditions were analyzed in four independent experiments with similar results. similar to the TTF-1 binding consensus (CTNNAG), TTF-1 may have the capacity to bind to the NF-B consensus sequence. Antibodies to NF-B proteins, p65 and p50, added alone or in combination considerably reduced the intensity of the TBE-nuclear protein complex (Fig. 5B) , whereas antibodies to TTF-1 caused an apparent supershift of the binding complex. On the other hand, antibodies to the transcription factor C/EBP-␤ (␣Nonsp.) and nonimmune IgG had no effect (Fig. 5B) to alter the intensity or mobility of the binding complex. Antibodies to p50 and p65 failed to interact with the TBE probe in the absence of type II cell nuclear proteins (␣p50 alone, ␣p65 alone). These findings suggest that NF-B proteins p50 and p65 are components, together with TTF-1, of the complex of type II cell nuclear proteins binding to the TBE.
In previous studies, we observed specific binding of a bacterially expressed TTF-1 homeodomain-containing peptide to the TBE (11) . In the present study, we assessed the binding to the TBE and to the NF-B consensus oligonucleotide of in vitro transcribed/ translated p50 and p65 proteins, alone and in combination. However, the expressed NF-B proteins failed to bind to either oligonucleotide probe (data not shown). This suggests that extensive posttranslational modification of NF-B is required for DNA binding activity. Therefore, it is uncertain as to whether p50 and p65 bind directly to the TBE, or whether they bind indirectly through their interactions with other proteins.
IL-1 Treatment of Human Fetal Type II Cells Causes a Rapid Induction of Nuclear Levels of Immunoreactive p50 and p65
In previous studies, we observed that cAMP had only a modest or even negligible effect to increase the rate of synthesis and nuclear levels of immunoreactive TTF-1. Rather, the marked stimulatory effect of Bt 2 cAMP on TTF-1-binding activity was due to an induction of TTF-1 phosphorylation (16) . In the case of NF-B, however, it has been reported that cytokine-mediated activation is associated with increased nuclear translocation, as well as by increased phosphorylation of p65 by PKA (19, 20) . In the present study, we analyzed the levels of p50, p65, and TTF-1 in type II cell nuclear extracts after 1, 3, 6, 24, and 72 h of incubation in the absence or presence of Bt 2 cAMP or IL-1␣. In this experiment, all type II cells were incubated for 72 h in serum-free culture medium; Bt 2 cAMP and IL-1 were added to the medium at the various time points before harvesting the cells. As can be seen, Bt 2 cAMP had little or no effect to alter nuclear levels of p50, p65 or TTF-1 at any of the time points studied (Fig. 6A) . On the other hand, IL-1␣ had a rapid effect (within 1 h) to increase nuclear levels of p50 and p65. In the case of p50, the stimulatory effect of IL-1␣ persisted throughout the 72-h incubation period. By contrast, the stimulatory effect of IL-1␣ on p65 levels was evident after 1-6 h of incubation but was greatly diminished after 24 h. Nuclear levels of immunoreactive TTF-1 were relatively unaffected by IL-1␣ at time points up to and including 6 h of incubation. However, after 24 h of incubation, the levels of immunoreactive TTF-1 in nuclear extracts of IL-1␣-treated type II cells were markedly reduced as compared with untreated cells or cells incubated with Bt 2 cAMP alone (Fig. 6A) .
Nuclear extracts from type II cells in the same timecourse experiment were analyzed for DNA binding activity using radiolabeled NF-B consensus (Fig. 6B) and TBE (Fig. 6C) oligonucleotides as probes. Interestingly, nuclear protein binding activity for both NF-B and TBE probes was maximally induced by IL-1␣ after 1 h of incubation. This level of binding activity was maintained throughout the 72 h incubation period (Fig. 6, B and C) . In nuclear extracts from Bt 2 cAMP-treated cells, a modest stimulatory effect on binding activity was evident within 3 h of incubation; maximal induction of binding activity by Bt 2 cAMP was observed after 24 h of treatment and persisted throughout the 72-h incubation period (Fig. 6 , B and C). Therefore, it is evident that binding activity remained elevated in nuclear extracts from IL-1-treated cells after 24 h of treatment, despite the decline in nuclear levels of p65 and TTF-1 proteins.
The NF-B Proteins p50 and p65 Act Synergistically with TTF-1 to Increase SP-A Promoter Activity in Transfected A549 Cells
To determine whether NF-B p50 and p65 functionally interact with TTF-1 at the TBE to regulate SP-A promoter activity, A549 lung adenocarcinoma cells were transfected with a fusion gene comprised of three copies of the TBE fused to the first 50 bp of 5Ј-flanking DNA and ϩ40 bp of the first exon of the bSP-A2 gene, linked upstream of the human GH (hGH) structural gene, as reporter (TBE 3 :hGH). The bSP-A2 gene contains three TBEs (11) . Although these differ in sequence, all have been found to bind expressed TTF-1 (11). As mentioned above, only TBE1 is highly conserved in sequence among the SP-A genes of various species and contains the reverse NF-B site. The TBE 3 :hGH reporter gene construct (which contains three tandem TBE1 sequences) was used to amplify the signal and to mimic the number of TBE sequences in the baboon and human SP-A genes. A549 cells were used for transfection because they do not express detectable levels of TTF-1 (16) . The cells were cotransfected with expression vectors containing p50, p65, or TTF-1, alone or in various combinations, in the absence or presence of IL-1␤; cytomegalovirus (CMV): ␤-galactosidase (␤-gal) was cotransfected as a control for transfection efficiency. Transcription of the reporter gene was evaluated by measuring the hGH that accumulated in the culture medium over a 24-h period, 39 h after transfection. As can be seen, transfection of p50 and p65 alone and in combination caused a modest induction of SP-A promoter activity, whereas TTF-1 alone increased SP-A promoter activity approximately 3-fold (Fig. 7A) . In cells cotransfected with TTF-1 and either p50 or p65, there was an additive effect on SP-A promoter activity; an even greater inductive effect was evident when p50, p65, and TTF-1 were cotransfected in combination (Fig. 7A) . In independent transfection experiments, A549 cells cotransfected with TBE 3 :hGH with or without expression vectors for TTF-1, p50ϩp65 (NF-B), alone and in combination were cultured in the absence or presence of IL-1␤ (10 ng/ml). As can be seen, IL-1␤ markedly enhanced the inductive effects on bSP-A2 promoter activity of TTF-1 and NF-B, transfected alone and in combination (Fig. 7B) . These findings indicate that NF-B proteins and TTF-1 cooperatively interact at the TBE to stimulate SP-A promoter activity, and that the inductive effects of these transcription factors are enhanced by IL-1.
DN Forms of IB-␣ and IB-␤ Inhibit Type II Cell Nuclear Protein Binding to the NF-B Consensus and TBE Oligonucleotides and Inhibit SP-A Expression
The data presented thus far, suggest that NF-B proteins act together with TTF-1 at the TBE to mediate induction of SP-A gene expression. To further define the role of endogenous NF-B in cAMP and IL-1 induction of type II cell nuclear protein binding activity and SP-A expression, human fetal type II cells in primary culture were infected with recombinant adenoviruses expressing DN forms of IB-␣ or IB-␤, or with a recombinant adenovirus containing CMV:␤gal as a control. The DN isoforms of IB contain mutations in the IB kinase phosphorylation sites and are resistant to degradation by the ubiquitin/proteasome pathway (28) . This enables the overexpressed IB proteins to sequester p65/p50 complexes within the cell, blocking activation of NF-B. Overexpression of DN IB-␣ and -␤ was confirmed by immunoblotting (data not shown). As can be seen in the immunoblot in Human fetal type II cells were cultured for 1, 3, 6, 24, and 72 h in control medium, in medium containing Bt 2 cAMP (Bt 2 , 1 mM), IL-1␣ (10 ng/ml), or Bt 2 cAMP plus IL-1␣. The levels of immunoreactive p50, p65 and TTF-1 in nuclear extracts were analyzed by immunoblotting using specific antibodies (A). Binding activities of type II cell nuclear proteins for radiolabeled NF-B consensus (B) and TBE (C) oligonucleotides were analyzed by EMSA. Shown are autoradiograms of immunoblots and EMSAs from a typical experiment that was repeated five times with similar results. and this increase was antagonized by infection with the DN-IB-expressing adenoviruses. Comparable inhibitory effects of the DN-IB isoforms were observed on nuclear protein binding to both NF-B (Fig. 8B) and TBE (Fig. 8C) probes. An inhibitory effect of DN-IB on TBE-binding activity of control nuclear extracts was also evident, suggesting that endogenous NF-B is important for basal levels of DNA binding activity. Together, these findings further suggest the importance of endogenous NF-B proteins in cAMP and cytokine induction of SP-A gene expression.
TTF-1 and p65 Interact in Vivo
From the findings presented thus far, it is evident that TTF-1 and NF-B proteins cooperatively interact at the TBE to stimulate SP-A promoter activity. In antibodymediated supershift EMSA (Fig. 5) , we have obtained evidence that p50 and p65 interact with the TBE; however, we have been unable to demonstrate that expressed p65 and p50 bind to the TBE directly. Because the expressed proteins also failed to bind to the NF-B consensus, we believe that this may be due to their inadequate posttranslational modification. To determine whether TTF-1 has the ability to interact with p50 and p65 in vivo, we carried out coimmunoprecipitation assays using type II cells incubated with Bt 2 cAMP ϩ IL-1␣ for 24 h. Nuclear extracts from the treated cells were immunoprecipitated using either preimmune rabbit IgG or rabbit antibodies to TTF-1, normal rabbit IgG or rabbit polyclonal antibodies to p50 and p65. The immunoprecipitated proteins were resolved by SDS-PAGE and analyzed for p65 by immunoblotting. As can be seen in the immunoblot in Fig. 9 , p65 was found to strongly interact with itself and with its heterodimeric partner, p50. Interestingly, p65 was also found to interact with TTF-1. Essentially no p65 was observed in the control IgG lanes. When the blot was reprobed using antibody to p50, no interaction with TTF-1 was evident, although there was strong interaction with itself and with p65 (data not shown). These findings indicate that TTF-1 may interact with NF-B through direct binding to p65.
DISCUSSION
SP-A is a lung-specific member of the collectin family that is believed to serve a role in innate immune defense within the alveolus by activating macrophages (3) . In the present study, we found that the inflammatory cytokines IL-1␣ and IL-1␤ increased SP-A expression in human fetal lung type II cells and had an additive stimulatory effect with Bt 2 cAMP. These effects on SP-A expression were associated with comparable inductive effects on binding of type II cell nuclear proteins to the TBE, a response element known to bind the homeodomain transcription factor TTF-1 (11), which is critical for cAMP induction of SP-A promoter activity (16) . We found these stimulatory effects of IL-1 to be of interest in light of the presence within the TBE of an overlapping reverse-oriented binding sequence for NF-B, a transcription factor complex that medi- ates the actions of IL-1 and other cytokines on expression of genes involved in immune regulation and inflammation (18) . IL-1 and Bt 2 cAMP treatment also increased binding of type II cell nuclear proteins to a NF-B consensus sequence; again, an additive stimulatory effect on binding activity was observed in cells treated with these factors in combination. The finding that antibodies to NF-B proteins p50 and p65 and TTF-1 reduced the binding of type II cell nuclear proteins to radiolabeled TBE suggests that NF-B exists together with TTF-1 in the complex that binds to this element. The potential role of endogenous NF-B in the regulation of SP-A gene expression was further supported by the significant finding that overexpression of DN forms of IB-␣ or IB-␤ inhibited cAMP and IL-1 induction of nuclear protein binding to the TBE and reduced SP-A expression in cultured type II cells.
A functional reverse-oriented NF-B site was first described in the 5Ј-flanking region of the murine Pselectin gene (27) . This novel sequence, which was found to be required for optimal induction by TNF-␣ and lipopolysaccharide of P-selectin promoter activity, was suggested to preferentially bind p65 homodimers (27) . It was proposed that this unusual element is functional because it binds to symmetrical homodimers, which do not require an orientationspecific NF-B binding site for transcriptional activation (27) . At present, it is not known as to whether TTF-1 and NF-B proteins have the capacity to bind Nuclear extracts isolated from human fetal lung type II cells cultured in medium containing Bt 2 cAMP ϩ IL-1␣ for 24 h were subjected to an immunoprecipitation protocol using rabbit antibodies to TTF-1, p50 or p65. Parallel samples were run using either rabbit preimmune IgG or nonimmune IgG, as controls. The immunoprecipitated samples were then analyzed for the presence of p65 by immunoblotting. Shown is an autoradiogram of an immunoblot from an experiment that was repeated twice with the same results.
simultaneously to the TBE site. In previous studies, we found that expressed TTF-1 homeodomain peptide binds specifically to the TBE (11) . In the present study, we were unable to ascertain whether in vitro transcribed/translated p50 or p65 have the capacity to bind to the TBE directly. However, the expressed proteins also failed to bind to the NF-B consensus sequence, suggesting that additional posttranslational modification of the NF-B proteins is required for binding activity. On the other hand, our observations in cotransfection assays that p50/p65 and TTF-1 act synergistically at the TBE to increase SP-A promoter activity suggest that all three factors cooperatively interact at the TBE. In coimmunoprecipitation assays using nuclear extracts from human type II cells treated with Bt 2 cAMP ϩ IL-1␣, we observed that TTF-1 and p65 interact in vivo, whereas interaction of TTF-1 with p50 was not detected. These findings suggest that p65/p50 heterodimer may interact with TTF-1 at the TBE through TTF-1⅐p65 binding.
In recent studies, we observed that TTF-1 binds to the coactivators CREB-binding protein (CBP) and steroid receptor coactivator-1 (SRC-1) in vitro (29) . CBP and SRC-1 were found to synergistically interact with TTF-1 at the TBE to increase SP-A promoter activity (29) . It also has been reported that p65 interacts with CBP and its structural homolog, p300 (19, 30) ; phosphorylation of p65 by PKA was found to increase transcriptional activity by enhancing its association with CBP (19) . On the other hand, p50 was observed to interact with SRC-1, and this interaction was found to enhance NF-B-mediated transcription (31) . In light of these findings, we suggest that TTF-1 and NF-B proteins may form a transcriptional activation complex at the TBE that is stabilized by bivalent or multivalent interactions with coactivators, which in turn mediate interaction and stabilization of the basal transcription complex and cause an opening of chromatin structure through their intrinsic histone acetylase activities.
To begin to compare the mechanisms whereby Bt 2 cAMP and IL-1 induce SP-A expression, their effects on nuclear levels of p65, p50, and TTF-1 and on nuclear protein binding activity were analyzed as a function of incubation time. Type II cell nuclear protein binding to both NF-B and TBE probes was found to be maximally induced by IL-1 within 1 h of incubation and remained elevated throughout the 72-h incubation period. This rapid induction of binding activity by IL-1 was associated with an equally rapid increase in nuclear levels of p50 and p65. Whereas the stimulatory effect of IL-1 on p50 levels persisted throughout the 72-h incubation period, nuclear levels of p65 were reduced to those of control type II cells after 24 and 72 h of incubation. This decline in nuclear levels of p65 in IL-1-treated type II cells may be caused by NF-Binduced activation of IB-␣ gene expression (see Ref.
18 for review) and reaccumulation of NF-B/IB complexes in the cytoplasm. Interestingly, the decrease in p65 levels was associated with a marked decrease in nuclear levels of TTF-1.
In contrast to the extremely rapid inductive effects of IL-1 on NF-B consensus and TBE binding, a stimulatory effect of Bt 2 cAMP was evident after 3 h of incubation; maximal levels were reached only after 24 h and were maintained throughout the 72-h incubation period. cAMP treatment of type II cells had little or no effect to alter nuclear levels of TTF-1, p50, or p65. Previously, we found that the stimulatory effect of Bt 2 cAMP on TBE binding activity in cultured type II cells was associated with increased phosphorylation of TTF-1; phosphatase treatment of nuclear extracts abolished DNA binding activity (16) . In A549 cell transfection studies, PKA catalytic subunit (PKA-cat) increased TTF-1 transcriptional activity (16) . It has also been reported that cytokines (32) and PKA (20) increase p65 phosphorylation and DNA binding activity. Our finding that binding of nuclear proteins to both NF-B and TBE probes remains elevated in IL-1-treated cells after 24 and 72 h of treatment, whereas nuclear levels of p65 and TTF-1 decline suggests that posttranslational modification of these proteins is a primary factor in their DNA binding activity. It also should be noted that TTF-1 is surprisingly abundant for a transcription factor. It, therefore, is possible that only a small pool of the total nuclear TTF-1 is involved in DNA binding and that this pool is unaffected by IL-1. The present findings, therefore, suggest that IL-1 and cAMP act through NF-B and TTF-1 to increase SP-A expression by different mechanisms, and that posttranslational modification of TTF-1 and p65 may have a greater influence on DNA binding and transcriptional activity than their absolute levels within the nucleus.
Activation of the NF-B pathway by a variety of factors, including cytokines, lipopolysaccharide, and ROS, results from phosphorylation, ubiquitination, and degradation of the inhibitory IB subunit and the release of active NF-B p50/p65 heterodimer to the nucleus (see Ref. 18 for review). The p65 component of the released and active NF-B heterodimer is phosphorylated at a specific PKA site, which enhances its DNA binding and transcriptional activity (20) . Recently, it was reported that PKA-cat is associated in an inactive complex with IB-␣ and -␤ in association with the NF-B complex. Stimulatory factors that promote degradation of IB cause the release and activation of the PKA-cat with phosphorylation of NF-B p65 (20) . This provides a mechanism for a cAMP-independent, cytokine-mediated activation of PKA and of NF-B. These findings, together with those of the present study, suggest that cAMP and IL-1 may exert additive effects on SP-A gene expression by facilitating increased activation of PKA with associated phosphorylation, DNA binding and transcriptional activation of both TTF-1 and NF-B. Our findings further suggest that activated TTF-1 and NF-B proteins exert their stimulatory effects on SP-A gene expression through binding to the TBE.
As mentioned above, we previously observed that O 2 has a dose-dependent, permissive effect on cAMP induction of SP-A gene expression in cultured human fetal lung (5) . In the present study, we found that treatment of cultured type II cells with the antioxidant inhibitors of NF-B, PDTC, and NAC, reduced nuclear protein binding to the NF-B consensus oligonucleotide and to the TBE, and blocked cAMP induction of SP-A gene expression. Our findings provide intriguing evidence that permissive effects of O 2 on cAMP induction of SP-A gene expression may be mediated by cooperative interaction of TTF-1 and NF-B at the TBE. NF-B is considered to be a redox-sensitive transcription factor; ROS appear to serve a permissive role in the activation of NF-B in response to a variety of inflammatory mediators in a number of different cell types (18, 21, 33) . Antioxidants, such as PDTC and NAC, block the activation of NF-B by various cytokines, lipopolysaccharide, and other inducers, suggesting the involvement of a common oxygen-sensitive intermediate; however, the precise step(s) sensitive to oxidative stress has not been determined. On the other hand, it has been proposed that one or more steps involving phosphorylation of IB by IB kinases and/or its degradation via the proteasome pathway may be regulated by oxidative stress (21) . In recent studies using fetal rat type II cells, it was found that NAC, a glutathione precursor and scavenger of ROS, decreased nuclear binding activity for an NF-B consensus sequence, while increasing DNA binding to a consensus sequence for hypoxia-inducible transcription factor-1␣ (34) . It was observed in those studies that binding of type II cell nuclear proteins to an NF-B consensus sequence was activated by subjecting the cells to acute increases in O 2 tension in association with an increase in the ratio of reduced to oxidized glutathione.
In summary, we have observed that cAMP and IL-1 have additive stimulatory effects on TBE-binding activity and on SP-A expression in human fetal lung type II cells. NF-B and TTF-1 proteins appear to cooperatively interact at the TBE to increase SP-A promoter activity. We also found that cAMP and IL-1 induction of TBE-binding activity and SP-A expression is strongly influenced by the redox state of the type II cell. ROS are likely to increase in epithelial cells of developing lung in association with increased vasculogenesis and O 2 delivery, and with associated decreases in cellular glutathione (35) and glutathione-S-transferases (GSTs) (36) . Our findings suggest that developmental increases in O 2 availability and ROS may serve a permissive role in cAMP and cytokine-mediated induction of SP-A gene expression through enhanced binding, activation and cooperative interaction of TTF-1 and NF-B at the TBE.
MATERIALS AND METHODS

Plasmids and Antisera
An expression vector (pCMV5/TTF-1) containing a fulllength cDNA encoding baboon TTF-1 (11) was constructed as described previously (16) . Expression vectors for NF-B proteins p50 and p65 [Rous sarcoma virus (RSV)/p50 and RSV/p65] were kindly provided by Dr. Richard Gaynor (UT Southwestern). A human GH (hGH) reporter plasmid (TBE 3 SP-A:hGH) containing a concatamer of three DNA repeats of bSP-A2 gene 5Ј-flanking sequences between Ϫ185 and Ϫ165 bp, containing TBE1 (underlined) (henceforth referred to as TBE, 5Ј-GTGCTCCCCTCAAGGGTC-CTA-3Ј) (11), was constructed as described previously (16) . Recombinant adenovirus DN forms of IB-␣ and IB-␤ containing mutations in the IB kinase serine phosphorylation sites (28) were generously provided by Dr. Richard Gaynor (UT Southwestern). A recombinant adenovirus containing CMV:␤gal was used as a control.
TTF-1 antiserum was raised in rabbits against bacterially expressed GST-TTF-1 1Ϫ50 peptide containing the N-terminal 50 amino acids of bTTF-1 (11). The antiserum was adsorbed with GST peptide to remove GST-specific antibodies. Specific rabbit polyclonal antibodies were raised against human SP-A protein isolated from alveolar lavage of a patient with alveolar proteinosis (4) . Rabbit antisera against NF-B p50 and p65 were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
Preparation and Culture of Human Fetal Lung Explants, Type II Cells, and Human Adenocarcinoma Cell Lines
Type II cells were isolated from cultured midgestation human fetal lung explants, as described previously (26) . Briefly, lung tissues from midgestation human abortuses were maintained in organ culture in serum-free Waymouth's MB752/1 medium (Life Technologies, Inc., Grand Island, NY) in the presence of Bt 2 cAMP to promote type II cell differentiation (4). After 3 d of culture, tissues were digested with collagenase; isolated cells were treated with diethylaminoethyl-dextran, and plated at a density of 5-9 ϫ 10 6 cells/60-mm dish. The cells were maintained overnight in Waymouth's medium containing 10% FBS, and then incubated for up to 3 d in serum-free Waymouth's medium in the absence or presence of Bt 2 cAMP (1 mM), IL-1␣ (10 ng/ml), IL-1␤ (10 ng/ml), or Bt 2 cAMP and IL-1 in combination. In some experiments, type II cells treated with cytokines and cAMP also were incubated with or without PDTC (25 M; Sigma, St. Louis, MO). The human lung adenocarcinoma cell line A549 (ATCC CCL 185) was maintained in Waymouth's medium containing 10% FBS.
EMSAs
Nuclear extracts were prepared from lung type II cells as described previously (37) . Protein concentrations were determined by a modified Bradford assay (Bio-Rad Laboratories, Inc., Richmond, CA). Double-stranded oligonucleotides corresponding to the TBE (TBE, underlined) and flanking sequences (5Ј-GTGCTCCCCTCAAGGGTCCT-3Ј) and an oligonucleotide corresponding to an NF-B consensus binding site (underlined) (5Ј-AGTTGAGGGGACTTTCCCAGGC-3Ј) (Integrated DNA Technologies, Inc., Coralville, IA) were endlabeled using [␥ 32 P]ATP (ICN Biomedicals, Costa Mesa, CA) and used as probes. Nuclear proteins (7 g) were incubated with 32 P-labeled TBE oligonucleotide for 30 min at room temperature in reaction buffer (20 mM HEPES, pH 7.6; 75 mM KCl; 0.2 mM EDTA; 20% glycerol) and 1 g of poly(deoxyinosine-deoxycytidine)-poly(deoxyinosine-deoxycytidine) (Amersham Pharmacia Biotech, Piscataway, NJ) as nonspecific competitor. Protein-DNA complexes were separated from free probe on a 4% nondenaturing polyacrylamide gel and visualized by autoradiography. For DNA competition EMSA, nonradiolabeled double-stranded oligonucleotides in 10-to 1000-fold molar excess of the radiolabeled probe were added simultaneously with radiolabeled probe. Supershift EMSA was performed by a 30-min incubation at room temperature of nuclear extracts with 1 l of antisera to TTF-1, p50, or p65 before incubation with the radiolabeled probe.
